The german experience in reference pricing. Catalogue en ligne

Titre :	The german experience in reference pricing. : L'expérience allemande du prix de référence. (1998)
Auteurs :	G. GIULIANI ; L. GARATTINI ; G. SELKE ; Mario Negri Institute for Pharmacological Research. Center for Health Economics. Ranica. ITA
Type de document :	Article
Dans :	Health policy (vol. 44, n° 1, 1998/04)
Pagination :	73-85
Langues:	Anglais
Mots-clés :	Médicament ; Prix ; Expérience ; Politique santé ; Système santé ; Maîtrise dépense ; Economie santé ; Allemagne
Résumé :	[BDSP. Notice produite par CREDES x99R0xmO. Diffusion soumise à autorisation]. This article concerns the reference price scheme wich concerns setting a price cap for each active ingredient, or group of active ingredients considered equivalent according to some feature (e.g. therapeutic effects and chemical structure). In 1989, the reference price scheme for reimbursable drugs was introduced in Germany to reduce pharmaceutical expenditure, which has been steadily increasing in the past. The study investigates the economic effects of introducing reference prices in Germany to order to assess whether this system has been effective in containing public pharmaceutical expenditure. We conclude that the reference prices scheme is an effective tool for price control, but cost containment requires further measures.

PORTAIL DOCUMENTAIRE